X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33529) 33529
Book Review (1955) 1955
Publication (987) 987
Newspaper Article (474) 474
Book Chapter (325) 325
Conference Proceeding (183) 183
Magazine Article (176) 176
Book / eBook (118) 118
Dissertation (80) 80
Trade Publication Article (55) 55
Reference (47) 47
Newsletter (24) 24
Government Document (18) 18
Web Resource (18) 18
Streaming Video (8) 8
Paper (7) 7
Journal / eJournal (3) 3
Manuscript (3) 3
Art (2) 2
Report (2) 2
Microfilm (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
castration (27707) 27707
index medicus (25178) 25178
animals (19307) 19307
male (18463) 18463
female (14830) 14830
humans (11803) 11803
rats (10307) 10307
estradiol - pharmacology (4221) 4221
prostate cancer (4143) 4143
testosterone - pharmacology (3415) 3415
pregnancy (3097) 3097
mice (3080) 3080
middle aged (2908) 2908
abridged index medicus (2781) 2781
oncology (2675) 2675
time factors (2540) 2540
orchiectomy (2414) 2414
aged (2356) 2356
old medline (2250) 2250
progesterone - pharmacology (2231) 2231
adult (2179) 2179
testosterone (2047) 2047
luteinizing hormone - blood (1804) 1804
urology & nephrology (1730) 1730
rats, inbred strains (1726) 1726
endocrinology & metabolism (1718) 1718
ovary - physiology (1699) 1699
cancer (1698) 1698
prostatic neoplasms, castration-resistant - drug therapy (1672) 1672
prostate (1656) 1656
research (1542) 1542
androgens (1530) 1530
sex factors (1444) 1444
metastasis (1435) 1435
prostatic neoplasms, castration-resistant - pathology (1420) 1420
adrenalectomy (1337) 1337
organ size (1323) 1323
prostatic neoplasms - drug therapy (1296) 1296
chemotherapy (1278) 1278
veterinary sciences (1238) 1238
neoplasm metastasis (1221) 1221
castration-resistant prostate cancer (1212) 1212
prostatic neoplasms - pathology (1187) 1187
estrus (1172) 1172
testosterone - blood (1127) 1127
androgen receptor (1101) 1101
docetaxel (1067) 1067
age factors (1060) 1060
care and treatment (1004) 1004
testis - physiology (988) 988
analysis (981) 981
expression (973) 973
follicle stimulating hormone - blood (971) 971
antineoplastic agents - therapeutic use (964) 964
hypophysectomy (945) 945
treatment outcome (941) 941
prognosis (939) 939
cell line, tumor (931) 931
survival (919) 919
sexual behavior, animal - drug effects (908) 908
body weight (907) 907
receptors, androgen - metabolism (894) 894
castration - veterinary (886) 886
aged, 80 and over (877) 877
dose-response relationship, drug (876) 876
estrogens - pharmacology (873) 873
men (864) 864
uterus - drug effects (848) 848
therapy (790) 790
luteinizing hormone - secretion (789) 789
enzalutamide (777) 777
kinetics (757) 757
metastases (752) 752
growth (741) 741
rabbits (725) 725
ovary (724) 724
tritium (724) 724
article (715) 715
cell biology (710) 710
dogs (703) 703
abiraterone acetate (702) 702
prostatic neoplasms, castration-resistant - metabolism (697) 697
prostatic neoplasms - metabolism (693) 693
abiraterone (682) 682
urology (680) 680
prostate - metabolism (657) 657
androgen antagonists - therapeutic use (651) 651
estradiol (645) 645
disease progression (644) 644
hormones (644) 644
estrogens (641) 641
radioimmunoassay (638) 638
agriculture, dairy & animal science (630) 630
cattle (630) 630
pharmacology & pharmacy (627) 627
sheep (625) 625
prostate - drug effects (623) 623
testosterone - metabolism (620) 620
tumors (620) 620
in vitro techniques (618) 618
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (46) 46
Online Resources - Online (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
UTL at Downsview - May be requested (8) 8
St. Michael's College (John M. Kelly) - 2nd Floor (7) 7
Gerstein Science - Stacks (5) 5
Media Commons - Microtexts (5) 5
UofT at Scarborough - Stacks (4) 4
Criminology - Stacks (3) 3
Law (Bora Laskin) - Stacks (3) 3
Regis College - Storage (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
East Asian (Cheng Yu Tung) - Stacks (2) 2
Music - Stacks (2) 2
OISE - Stacks (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (2) 2
Institute for Christian Studies - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Scarborough - Oversize (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (29795) 29795
French (1253) 1253
German (1207) 1207
Russian (698) 698
Japanese (486) 486
Italian (396) 396
Spanish (304) 304
Portuguese (156) 156
Polish (126) 126
Chinese (76) 76
Dutch (60) 60
Czech (57) 57
Korean (47) 47
Hungarian (43) 43
Bulgarian (32) 32
Swedish (21) 21
Ukrainian (20) 20
Romanian (14) 14
Croatian (13) 13
Danish (11) 11
Finnish (11) 11
Norwegian (11) 11
Serbian (11) 11
Hebrew (10) 10
Slovak (8) 8
Turkish (6) 6
Afrikaans (4) 4
Latin (3) 3
Arabic (2) 2
Indonesian (2) 2
Persian (2) 2
Greek (1) 1
Hindi (1) 1
Lithuanian (1) 1
Slovenian (1) 1
Welsh (1) 1
Yiddish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


L'Homme et la Société, ISSN 0018-4306, 01/2017, Issue 203/204, pp. 338 - 344
Pour notre part, nous pensons, en tant que psychanalysant, que, sans faire référence a des cultes d'ancetres, le psychanalyste peut, lui aussi, réinsérer le... 
Castration
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 18, pp. 3532 - 3539
Platinum‐based chemotherapy does not play a significant role in the management of advanced prostate cancer. In the current study, patients with metastatic... 
DNA damage repair | prostate cancer | carboplatin | breast cancer 2 | ) | castration resistance | BRCA2 | breast cancer 2 (BRCA2) | SURVIVAL | MUTATION CARRIERS | GUIDELINES | OVARIAN-CANCER | DISCOVERY | IMPACT | GENOMICS | THERAPY | ONCOLOGY | FRAMEWORK | DNA-SEQUENCING DATA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Taxoids - therapeutic use | Neoplasm Metastasis | Carboplatin - therapeutic use | Neoplasm Invasiveness - pathology | Genes, BRCA2 | Germ-Line Mutation | Adult | Retrospective Studies | Genetic Predisposition to Disease | Prostatic Neoplasms, Castration-Resistant - drug therapy | Cancer Care Facilities | Prostate-Specific Antigen - blood | Disease-Free Survival | Survival Analysis | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Neoplasm Staging | Cohort Studies | Care and treatment | Chemotherapy | Usage | Men | Gene therapy | Prostate cancer | Health aspects | Cancer | Prostate-specific antigen | Medical services | Metastasis | Taxane | Blood | Metastases | Gene sequencing | Confidence intervals | Castration | Platinum | Consultation | Deoxyribonucleic acid--DNA | BRCA2 protein | Antigens | Breast cancer | Tumor cell lines | Patients | Current carriers | Corrosion resistance | Carboplatin | Breast | Mutation | Prostate | DNA sequencing | Index Medicus | Abridged Index Medicus | castration-resistance
Journal Article
1991, Di 1 ban., ISBN 9620751264, ii, v, 173
Book
BJU International, ISSN 1464-4096, 11/2017, Volume 120, Issue 5B, pp. E30 - E44
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 1, pp. 150 - 158
Abstract Background The phosphatase and tensin homolog ( PTEN ) tumor suppressor gene is deregulated in many advanced prostate cancers, leading to activation... 
Urology | Castration-resistant prostate cancer | Biomarker | Proteomics | mTOR inhibitor | PTEN | Everolimus | Immune system | MAMMALIAN TARGET | RAPAMYCIN | CELLS | ACTIVATION | TESTOSTERONE | AKT | PTEN GENOMIC DELETION | INHIBITION | PATHWAY | UROLOGY & NEPHROLOGY | RAD001 | Prospective Studies | Prostatic Neoplasms, Castration-Resistant - enzymology | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Prostatic Neoplasms, Castration-Resistant - immunology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Prostatic Neoplasms, Castration-Resistant - pathology | Dose-Response Relationship, Drug | TOR Serine-Threonine Kinases - antagonists & inhibitors | Time Factors | Antineoplastic Agents - adverse effects | T-Lymphocytes - drug effects | Kallikreins - blood | Sirolimus - adverse effects | PTEN Phosphohydrolase - genetics | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Prostatic Neoplasms, Castration-Resistant - blood | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Disease Progression | Prostate-Specific Antigen - blood | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | T-Lymphocytes - immunology | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Chemotherapy | Angiogenesis inhibitors | Prostate cancer | Cancer | Tumors | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 5, pp. 815 - 825
Abstract Background Abiraterone acetate (an androgen biosynthesis inhibitor) plus prednisone is approved for treating patients with metastatic... 
Urology | Chemotherapy-naive | Efficacy | Safety | Metastatic castration-resistant prostate cancer | Abiraterone acetate | prostate cancer | Metastatic castration-resistant | PLACEBO | DOCETAXEL CHEMOTHERAPY | PHASE-3 | TRIAL | MITOXANTRONE PLUS PREDNISONE | THERAPY | MEN | UROLOGY & NEPHROLOGY | INCREASED SURVIVAL | LIFE | Neoplasms, Hormone-Dependent - mortality | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms, Castration-Resistant - enzymology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytochrome P-450 Enzyme Inhibitors - adverse effects | Male | Abiraterone Acetate | Prostatic Neoplasms, Castration-Resistant - pathology | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Time Factors | Neoplasms, Hormone-Dependent - enzymology | Prednisone - administration & dosage | Androstenes - adverse effects | Double-Blind Method | Drug Administration Schedule | Antineoplastic Agents, Hormonal - administration & dosage | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Androstenes - administration & dosage | Cytochrome P-450 Enzyme Inhibitors - administration & dosage | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Steroid 17-alpha-Hydroxylase - metabolism | Neoplasms, Hormone-Dependent - drug therapy | Medical colleges | Cancer patients | Care and treatment | Chemotherapy | Corticosteroids | Analysis | Metastasis | Prostate cancer | Acetates | Cancer | Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1589 - 1604
Journal Article
1994, Chu ban., Ren xing jie zhou xi lie, ISBN 9578974043, Volume 1, 214
Book
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 26, pp. 2465 - 2474
Journal Article
The Prostate, ISSN 0270-4137, 07/2018, Volume 78, Issue 10, pp. 766 - 772
Journal Article